BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29748447)

  • 21. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Factors for Chronic Lymphocytic Leukemia.
    Chen C; Puvvada S
    Curr Hematol Malig Rep; 2016 Feb; 11(1):37-42. PubMed ID: 26748932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
    Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
    Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
    Matutes E; Polliack A
    Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
    Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
    Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
    Amaya-Chanaga CI; Rassenti LZ
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
    Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in chronic lymphocytic leukemia.
    Vyas N; Hassan A
    Indian J Cancer; 2012; 49(1):137-43. PubMed ID: 22842181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia with t(14;18)(q32;q21).
    Tang G; Banks HE; Sargent RL; Medeiros LJ; Abruzzo LV
    Hum Pathol; 2013 Apr; 44(4):598-605. PubMed ID: 23084581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
    Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
    Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
    Vetro C; Haferlach T; Jeromin S; Stengel A; Zenger M; Nadarajah N; Baer C; Weissmann S; Kern W; Meggendorfer M; Haferlach C
    Br J Haematol; 2018 Oct; 183(1):47-59. PubMed ID: 30022491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
    Nabhan C; Raca G; Wang YL
    JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part I. B-cell lymphocytic leukemia with TP53 gene deletion].
    Koczkodaj D; Rupniewska ZM; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 2003 Dec; 110(6):1395-403. PubMed ID: 15052934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
    Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
    N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.